RCAMU
KYNB

Rothschild & Co Asset Management US’s Kyntra Bio KYNB Stock Holding History

Rothschild & Co Asset Management US’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,553
Closed -$5.03M – 273
2021
Q2 		$5.03M Sell
7,553
-8,993
-54% -$5.18M 0.06% 220
2021
Q1 		$14.4M Sell
16,546
-4,684
-22% -$4.99M 0.18% 160
2020
Q4 		$19.7M Sell
21,230
-2,792
-12% -$2.93M 0.25% 137
2020
Q3 		$24.7M Sell
24,022
-2,623
-10% -$2.82M 0.44% 86
2020
Q2 		$27M Buy
26,645
+21,364
+405% +$19.8M 0.4% 92
2020
Q1 		$4.59M Sell
5,281
-1,147
-18% -$1.14M 0.07% 254
2019
Q4 		$6.89M Buy
6,428
+633
+11% +$646K 0.07% 271
2019
Q3 		$5.36M Sell
5,795
-68
-1% -$74.7K 0.06% 280
2019
Q2 		$6.62M Buy
5,863
+352
+6% +$385K 0.07% 275
2019
Q1 		$7.49M Sell
5,511
-661
-11% -$896K 0.08% 271
2018
Q4 		$7.14M Buy
6,172
+348
+6% +$391K 0.09% 274
2018
Q3 		$8.85M Sell
5,824
-146
-2% -$225K 0.09% 277
2018
Q2 		$9.34M Buy
5,970
+54
+0.9% +$70.4K 0.1% 270
2018
Q1 		$6.83M Sell
5,916
-238
-4% -$313K 0.08% 274
2017
Q4 		$7.29M Sell
6,154
-778
-11% -$976K 0.08% 268
2017
Q3 		$9.32M Sell
6,932
-309
-4% -$326K 0.1% 259
2017
Q2 		$5.85M Sell
7,241
-199
-3% -$139K 0.07% 277
2017
Q1 		$4.58M Buy
7,440
+38
+0.5% +$23.1K 0.05% 281
2016
Q4 		$3.96M Buy
7,402
+2,128
+40% +$1.06M 0.05% 297
2016
Q3 		$2.73M Buy
5,274
+227
+4% +$107K 0.05% 296
2016
Q2 		$2.07M Buy
5,047
+444
+10% +$203K 0.04% 319
2016
Q1 		$2.45M Buy
4,603
+169
+4% +$84.2K 0.05% 290
2015
Q4 		$3.38M Buy
4,434
+1,731
+64% +$1.15M 0.06% 295
2015
Q3 		$1.48M Buy
+2,703
New +$1.64M 0.03% 316

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rothschild & Co Asset Management US's KYNB Position: Q3 2021 in Review

Rothschild & Co Asset Management US sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 7,553 shares — an estimated $5.03M sold.

Rothschild & Co Asset Management US first reported a position in KYNB in Q3 2015 and held it in 24 quarters. The position peaked at $27M in Q2 2020. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.

  • Rothschild & Co Asset Management US reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 7,553 Kyntra Bio shares in Q3 2021, an estimated $5.03M.
  • Rothschild & Co Asset Management US first reported a position in Kyntra Bio in Q3 2015 and held it in 24 quarters.
  • Rothschild & Co Asset Management US's Kyntra Bio position peaked at $27M in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.

Based on Rothschild & Co Asset Management US's 13F filing for Q3 2021, filed 9 Nov 2021.